Shandong Boan Biotechnology Co., Ltd. (HKG:6955)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.81
-0.06 (-0.87%)
At close: Apr 29, 2026
-37.75%
Market Cap 4.24B
Revenue (ttm) 873.36M
Net Income (ttm) 7.95M
Shares Out 622.33M
EPS (ttm) 0.01
PE Ratio 533.10
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,038,400
Average Volume 5,731,860
Open 6.79
Previous Close 6.87
Day's Range 6.72 - 6.90
52-Week Range 6.12 - 19.90
Beta -0.06
RSI 45.85
Earnings Date May 27, 2026

About HKG:6955

Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China. The company offers Boyounuo (BA1101), an anti-VEGF humanized monoclonal antibody injection for mCRC, advanced metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, epithelial ovarian, fallopian tube, primary peritoneal cancer, cervical cancer, and hepatocellular carcinoma indications; Boyoubei (BA6101), a human immunoglobulin G2 monoclonal antibody of the RANK ligand for the treatment of post... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 714
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6955
Full Company Profile

Financial Performance

In 2025, HKG:6955's revenue was 784.82 million, an increase of 8.06% compared to the previous year's 726.32 million. Earnings were 7.14 million, a decrease of -90.24%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.